Calculation of survival of patients with stage III melanoma [1]

Journal of Clinical Oncology

Volumn 23, Issue 36, 2005, Pages 9427-

  Berd, David ^a   Mastrangelo, Michael J ^a   Sato, Takami ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CANCER SURVIVAL; HUMAN; LETTER; LYMPH NODE METASTASIS; MELANOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; MORTALITY; NOTE; PROGNOSIS; REPRODUCIBILITY; SKIN TUMOR; SURVIVAL; ULCER;

HUMANS; MELANOMA; NEOPLASM STAGING; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SKIN NEOPLASMS; SURVIVAL ANALYSIS; ULCER;

EID: 33644823159     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.6970     Document Type: Letter

References (2)

1. Balch CM, Soong S-J, Gershenwald JE, et al: Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622-3634, 2001
2. Berd D, Sato T, Maguire HC Jr, et al: Immunopharmacological analysis of an autologous, hapten-modified human melanoma vaccine. J Clin Oncol 22:403-415, 2004